Raju Mohan Biography and Net Worth

CEO of Ventyx Biosciences

Raju founded Ventyx Biosciences and has served as a member of our board of directors since the company’s inception. Prior to Ventyx, Raju founded Akarna Therapeutics, which was acquired by Allergan for up to $1.2B. In addition to Ventyx, Raju has founded Oppilan Pharma, Zomagen Biosciences, Escalier Biosciences and Vimalan Biosciences, all immunology-focused specialty pharmaceutical companies. From 2006 to 2011, Raju served as Vice President and head of the San Diego site for Exelixis and Vice President of Chemistry at X-Ceptor Therapeutics (acquired by Exelixis). Raju started his pharmaceutical career at Berlex Biosciences, a subsidiary of Bayer/Schering AG, where he held positions of increasing responsibility. Raju is responsible for the discovery of multiple small molecule drug candidates that have entered clinical trials. He is the inventor of MINNEBRO^®, an approved therapeutic for hypertension. He has published extensively in peer-reviewed journals and is an inventor on 64 issued US patents. Raju received a PhD in Chemistry from the University of Illinois and a Master’s degree from the Indian Institute of Technology.

What is Raju Mohan's net worth?: The estimated net worth of Raju Mohan is at least $33.15 million as of December 18th, 2025. Mohan owns 2,372,863 shares of Ventyx Biosciences stock worth more than $33,148,896 as of February 15th. This net worth evaluation does not reflect any other assets that Mohan may own. Additionally, Mohan receives an annual salary of $905,290.00 as CEO at Ventyx Biosciences. Learn More about Raju Mohan's net worth.
How old is Raju Mohan?: Mohan is currently 66 years old. There are 5 older executives and no younger executives at Ventyx Biosciences. Learn More on Raju Mohan's age.
What is Raju Mohan's salary?: As the CEO of Ventyx Biosciences, Inc., Mohan earns $905,290.00 per year. Learn More on Raju Mohan's salary.
How do I contact Raju Mohan?: The corporate mailing address for Mohan and other Ventyx Biosciences executives is , , . Ventyx Biosciences can also be reached via phone at 760-593-4832 and via email at [email protected]. Learn More on Raju Mohan's contact information.
Has Raju Mohan been buying or selling shares of Ventyx Biosciences?: Raju Mohan has not been actively trading shares of Ventyx Biosciences during the last quarter. Most recently, Raju Mohan sold 47,345 shares of the business's stock in a transaction on Thursday, December 18th. The shares were sold at an average price of $7.72, for a transaction totalling $365,503.40. Following the completion of the sale, the chief executive officer now directly owns 2,372,863 shares of the company's stock, valued at $18,318,502.36. Learn More on Raju Mohan's trading history.
Who are Ventyx Biosciences' active insiders?: Ventyx Biosciences' insider roster includes Sheila Gujrathi (Director), Christopher Krueger (Insider), Raju Mohan (CEO), and John Nuss (Insider). Learn More on Ventyx Biosciences' active insiders.
Are insiders buying or selling shares of Ventyx Biosciences?: During the last year, insiders at the sold shares 2 times. They sold a total of 60,020 shares worth more than $463,354.40. The most recent insider tranaction occured on December, 18th when CEO Raju Mohan sold 47,345 shares worth more than $365,503.40. Insiders at Ventyx Biosciences own 14.5% of the company. Learn More about insider trades at Ventyx Biosciences.
Information on this page was last updated on 12/18/2025.

Raju Mohan Insider Trading History at Ventyx Biosciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/18/2025	Sell	47,345	$7.72	$365,503.40	2,372,863
11/25/2024	Buy	261,752	$2.01	$526,121.52	2,175,028
11/22/2024	Buy	238,248	$1.83	$435,993.84	1,913,276
4/2/2024	Sell	4,312	$5.40	$23,284.80	1,578,250
12/20/2023	Sell	58,860	$2.12	$124,783.20	1,570,719
10/5/2023	Sell	30,000	$29.11	$873,300.00	1,512,911
8/7/2023	Sell	30,000	$33.52	$1,005,600.00	1,512,911
7/5/2023	Sell	30,000	$38.37	$1,151,100.00	1,512,911
6/5/2023	Sell	30,000	$34.36	$1,030,800.00	1,513,126
5/5/2023	Sell	30,000	$39.28	$1,178,400.00	1,543,126
4/10/2023	Sell	9,255	$29.01	$268,487.55	1,573,126
4/5/2023	Sell	13,230	$29.81	$394,386.30	1,589,896
12/22/2022	Sell	55,354	$31.61	$1,749,739.94	1,603,126
12/5/2022	Sell	23,003	$28.44	$654,205.32	1,541,811
12/2/2022	Sell	276,997	$29.01	$8,035,682.97	1,564,814

Raju Mohan Buying and Selling Activity at Ventyx Biosciences

Ventyx Biosciences Company Overview

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. The company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease. It is also developing VTX002, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in San Diego, California.

Today's Range

Now: $13.97

$13.93

$13.97

50 Day Range

MA: $11.63

$7.69

$14.03

2 Week Range

Now: $13.97

$0.78

$25.00

Volume

2,530,427 shs

Average Volume

2,201,694 shs

Market Capitalization

$1.00 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.25

Raju Mohan Biography and Net Worth

What is Raju Mohan's net worth?

How old is Raju Mohan?

What is Raju Mohan's salary?

How do I contact Raju Mohan?

Has Raju Mohan been buying or selling shares of Ventyx Biosciences?

Who are Ventyx Biosciences' active insiders?

Are insiders buying or selling shares of Ventyx Biosciences?